Mechanisms of tumor evasion from the immune response
- 1 January 2003
- book chapter
- Published by Elsevier
- Vol. 21, 351-364
- https://doi.org/10.1016/s0921-4410(03)21018-8
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Regulation of T Cell Receptor CD3ζ Chain Expression byl-ArginineJournal of Biological Chemistry, 2002
- Regulation of Nitric Oxide Production by Arginine Metabolic EnzymesBiochemical and Biophysical Research Communications, 2000
- CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancerInternational Journal of Cancer, 1998
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Development of immunogenic colorectal cancer cell lines for vaccination: Expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitroEuropean Journal Of Cancer, 1995
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Signal transduction events leading to T-cell lymphokine gene expressionImmunology Today, 1993
- Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.The Journal of Experimental Medicine, 1984